Abstract
Disease-associated astrocyte subsets contribute to the pathology of neurologic diseases, including multiple sclerosis and experimental autoimmune encephalomyelitis1,2,3,4,5,6,7,8 (EAE), an experimental model for multiple sclerosis. However, little is known about the stability of these astrocyte subsets and their ability to integrate past stimulation events. Here we report the identification of an epigenetically controlled memory astrocyte subset that exhibits exacerbated pro-inflammatory responses upon rechallenge. Specifically, using a combination of single-cell RNA sequencing, assay for transposase-accessible chromatin with sequencing, chromatin immunoprecipitation with sequencing, focused interrogation of cells by nucleic acid detection and sequencing, and cell-specific in vivo CRISPR–Cas9-based genetic perturbation studies we established that astrocyte memory is controlled by the metabolic enzyme ATP-citrate lyase (ACLY), which produces acetyl coenzyme A (acetyl-CoA) that is used by histone acetyltransferase p300 to control chromatin accessibility. The number of ACLY+p300+ memory astrocytes is increased in acute and chronic EAE models, and their genetic inactivation ameliorated EAE. We also detected the pro-inflammatory memory phenotype in human astrocytes in vitro; single-cell RNA sequencing and immunohistochemistry studies detected increased numbers of ACLY+p300+ astrocytes in chronic multiple sclerosis lesions. In summary, these studies define an epigenetically controlled memory astrocyte subset that promotes CNS pathology in EAE and, potentially, multiple sclerosis. These findings may guide novel therapeutic approaches for multiple sclerosis and other neurologic diseases.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
Sequencing data were deposited into GEO under the SuperSeries accession numbers GSE252551, GSE237558 and GSE252498. Source data are provided with this paper.
References
Rothhammer, V. et al. Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor. Nat. Med. 22, 586–597 (2016).
Wheeler, M. A. et al. MAFG-driven astrocytes promote CNS inflammation. Nature 578, 593–599 (2020).
Sanmarco, L. M. et al. Gut-licensed IFNγ+ NK cells drive LAMP1+TRAIL+ anti-inflammatory astrocytes. Nature 590, 473–479 (2021).
Wheeler, M. A. et al. Environmental control of astrocyte pathogenic activities in CNS inflammation. Cell 176, 581–596.e518 (2019).
Wheeler, M. A. et al. Droplet-based forward genetic screening of astrocyte-microglia cross-talk. Science 379, 1023–1030 (2023).
Clark, I. C. et al. Barcoded viral tracing of single-cell interactions in central nervous system inflammation. Science 372, eabf1230 (2021).
Rothhammer, V. et al. Microglial control of astrocytes in response to microbial metabolites. Nature 557, 724–728 (2018).
Chao, C. C. et al. Metabolic control of astrocyte pathogenic activity via cPLA2-MAVS. Cell 179, 1483–1498.e1422 (2019).
Allen, N. J. & Lyons, D. A. Glia as architects of central nervous system formation and function. Science 362, 181–185 (2018).
Lee, H. G., Wheeler, M. A. & Quintana, F. J. Function and therapeutic value of astrocytes in neurological diseases. Nat. Rev. Drug Discov. 21, 339–358 (2022).
Sofroniew, M. V. Astrocyte barriers to neurotoxic inflammation. Nat. Rev. Neurosci. 16, 249–263 (2015).
Yu, X. & Khakh, B. S. SnapShot: astrocyte interactions. Cell 185, 220–220.e221 (2022).
Lee, H. G., Lee, J. H., Flausino, L. E. & Quintana, F. J. Neuroinflammation: an astrocyte perspective. Sci. Transl. Med. 15, eadi7828 (2023).
Liddelow, S. A. et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541, 481–487 (2017).
Endo, F. et al. Molecular basis of astrocyte diversity and morphology across the CNS in health and disease. Science 378, eadc9020 (2022).
Habib, N. et al. Disease-associated astrocytes in Alzheimer’s disease and aging. Nat. Nerosci. 23, 701–706 (2020).
Zinkernagel, R. M. et al. On immunological memory. Annu. Rev. Immunol. 14, 333–367 (1996).
Wendeln, A. C. et al. Innate immune memory in the brain shapes neurological disease hallmarks. Nature 556, 332–338 (2018).
Saeed, S. et al. Epigenetic programming of monocyte-to-macrophage differentiation and trained innate immunity. Science 345, 1251086 (2014).
Sun, J. C., Beilke, J. N. & Lanier, L. L. Adaptive immune features of natural killer cells. Nature 457, 557–561 (2009).
Serafini, N. et al. Trained ILC3 responses promote intestinal defense. Science 375, 859–863 (2022).
Netea, M. G. et al. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol. 20, 375–388 (2020).
Perkins, N. D. et al. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275, 523–527 (1997).
Zhao, J., Li, X., Guo, M., Yu, J. & Yan, C. The common stress responsive transcription factor ATF3 binds genomic sites enriched with p300 and H3K27ac for transcriptional regulation. BMC Genomics 17, 335 (2016).
Magistretti, P. J. & Allaman, I. Lactate in the brain: from metabolic end-product to signalling molecule. Nat. Rev. Neurosci. 19, 235–249 (2018).
Pietrocola, F., Galluzzi, L., Bravo-San Pedro, J. M., Madeo, F. & Kroemer, G. Acetyl coenzyme A: a central metabolite and second messenger. Cell Metab. 21, 805–821 (2015).
Wellen, K. E. et al. ATP-citrate lyase links cellular metabolism to histone acetylation. Science 324, 1076–1080 (2009).
Mayo, L. et al. Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. Nat. Med. 20, 1147–1156 (2014).
Clark, I. C. et al. Identification of astrocyte regulators by nucleic acid cytometry. Nature 614, 326–333 (2023).
Absinta, M. et al. A lymphocyte-microglia-astrocyte axis in chronic active multiple sclerosis. Nature 597, 709–714 (2021).
Schirmer, L. et al. Neuronal vulnerability and multilineage diversity in multiple sclerosis. Nature 573, 75–82 (2019).
Cheong, J. G. et al. Epigenetic memory of coronavirus infection in innate immune cells and their progenitors. Cell 186, 3882–3902.e3824 (2023).
Yao, Y. et al. Induction of autonomous memory alveolar macrophages requires T cell help and is critical to trained immunity. Cell 175, 1634–1650.e1617 (2018).
McCarthy, G. F. & Leblond, C. P. Radioautographic evidence for slow astrocyte turnover and modest oligodendrocyte production in the corpus callosum of adult mice infused with 3H-thymidine. J. Comp. Neurol. 271, 589–603 (1988).
Chierzi, S. et al. Astrocytes transplanted during early postnatal development integrate, mature, and survive long term in mouse cortex. J. Neurosci. 43, 1509–1529 (2023).
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H. & Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87, 953–959 (1996).
Li, Q., Xiao, H. & Isobe, K. Histone acetyltransferase activities of cAMP-regulated enhancer-binding protein and p300 in tissues of fetal, young, and old mice. J. Gerontol. A 57, B93–B98 (2002).
Farrelly, L. A. et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature 567, 535–539 (2019).
Lepack, A. E. et al. Dopaminylation of histone H3 in ventral tegmental area regulates cocaine seeking. Science 368, 197–201 (2020).
Mews, P. et al. Acetyl-CoA synthetase regulates histone acetylation and hippocampal memory. Nature 546, 381–386 (2017).
Sen, P. et al. Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence. Mol. Cell 73, 684–698.e688 (2019).
Furman, D. et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 25, 1822–1832 (2019).
Li, T. Y. et al. The transcriptional coactivator CBP/p300 is an evolutionarily conserved node that promotes longevity in response to mitochondrial stress. Nat Aging 1, 165–178 (2021).
Burda, J. E. et al. Divergent transcriptional regulation of astrocyte reactivity across disorders. Nature 606, 557–564 (2022).
Chen, L., Fischle, W., Verdin, E. & Greene, W. C. Duration of nuclear NF-κB action regulated by reversible acetylation. Science 293, 1653–1657 (2001).
Long, L. et al. CRISPR screens unveil signal hubs for nutrient licensing of T cell immunity. Nature 600, 308–313 (2021).
Beigneux, A. P. et al. ATP-citrate lyase deficiency in the mouse. J. Biol. Chem. 279, 9557–9564 (2004).
Hochrein, S. M. et al. The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming. Cell Metab. 34, 516–532.e511 (2022).
Balmer, M. L. et al. Memory CD8+ T cells require increased concentrations of acetate induced by stress for optimal function. Immunity 44, 1312–1324 (2016).
Lauterbach, M. A. et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity 51, 997–1011.e1017 (2019).
Sardar, D. et al. Induction of astrocytic Slc22a3 regulates sensory processing through histone serotonylation. Science 380, eade0027 (2023).
Krausgruber, T. et al. Structural cells are key regulators of organ-specific immune responses. Nature 583, 296–302 (2020).
Hatzivassiliou, G. et al. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 8, 311–321 (2005).
Verschueren, K. H. G. et al. Structure of ATP citrate lyase and the origin of citrate synthase in the Krebs cycle. Nature 568, 571–575 (2019).
Wei, J. et al. An allosteric mechanism for potent inhibition of human ATP-citrate lyase. Nature 568, 566–570 (2019).
Garcia, A. D., Doan, N. B., Imura, T., Bush, T. G. & Sofroniew, M. V. GFAP-expressing progenitors are the principal source of constitutive neurogenesis in adult mouse forebrain. Nat. Neurosci. 7, 1233–1241 (2004).
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
Everhart, M. B. et al. Duration and intensity of NF-κB activity determine the severity of endotoxin-induced acute lung injury. J. Immunol. 176, 4995–5005 (2006).
Gutierrez-Vazquez, C. & Quintana, F. J. Protocol for in vitro analysis of pro-inflammatory and metabolic functions of cultured primary murine astrocytes. STAR Protoc. 3, 101033 (2022).
Thompson, A. J. et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162–173 (2018).
Dhaeze, T. et al. CD70 defines a subset of proinflammatory and CNS-pathogenic TH1/TH17 lymphocytes and is overexpressed in multiple sclerosis. Cell Mol. Immunol. 16, 652–665 (2019).
Broux, B. et al. Interleukin-26, preferentially produced by TH17 lymphocytes, regulates CNS barrier function. Neurol. Neuroimmunol. Neuroinflamm. 7, e870 (2020).
Illouz, T., Madar, R., Hirsh, T., Biragyn, A. & Okun, E. Induction of an effective anti-amyloid-β humoral response in aged mice. Vaccine 39, 4817–4829 (2021).
Illouz, T. et al. Maternal antibodies facilitate amyloid-β clearance by activating Fc-receptor–Syk-mediated phagocytosis. Commun. Biol. 4, 329 (2021).
Motulsky, H. J. & Brown, R. E. Detecting outliers when fitting data with nonlinear regression—a new method based on robust nonlinear regression and the false discovery rate. BMC Bioinformatics 7, 123 (2006).
Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783–784 (2014).
Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246–1260 (2015).
Lee, Y., Messing, A., Su, M. & Brenner, M. GFAP promoter elements required for region-specific and astrocyte-specific expression. Glia 56, 481–493 (2008).
Wang, T. et al. Gene essentiality profiling reveals gene networks and synthetic lethal interactions with oncogenic Ras. Cell 168, 890–903.e815 (2017).
Foo, L. C. Purification of rat and mouse astrocytes by immunopanning. Cold Spring Harb. Protoc. 2013, 421–432 (2013).
Lemaitre, F. et al. Capturing T lymphocytes’ dynamic interactions with human neural cells using time-lapse microscopy. Front. Immunol. 12, 668483 (2021).
Durafourt, B. A., Moore, C. S., Blain, M. & Antel, J. P. Isolating, culturing, and polarizing primary human adult and fetal microglia. Methods Mol. Biol. 1041, 199–211 (2013).
Kieran, N. W. et al. MicroRNA-210 regulates the metabolic and inflammatory status of primary human astrocytes. J. Neuroinflammation 19, 10 (2022).
van Galen, P. et al. A multiplexed system for quantitative comparisons of chromatin landscapes. Mol. Cell 61, 170–180 (2016).
Untergasser, A. et al. Primer3—new capabilities and interfaces. Nucleic Acids Res. 40, e115 (2012).
Trombetta, J. J. et al. Preparation of single-cell RNA-seq libraries for next generation sequencing. Curr. Protoc. Mol. Biol. 107, 4.22.1–4.22.17 (2014).
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
Tarasov, A., Vilella, A. J., Cuppen, E., Nijman, I. J. & Prins, P. Sambamba: fast processing of NGS alignment formats. Bioinformatics 31, 2032–2034 (2015).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Ramirez, F., Dundar, F., Diehl, S., Gruning, B. A. & Manke, T. deepTools: a flexible platform for exploring deep-sequencing data. Nucleic Acids Res. 42, W187–191 (2014).
Zhang, Y. et al. Model-based analysis of ChIP-seq (MACS). Genome Biol. 9, R137 (2008).
Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213–1218 (2013).
Buenrostro, J. D., Wu, B., Chang, H. Y. & Greenleaf, W. J. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 109, 21.29.21–21.29.29 (2015).
Clark, I. C., Thakur, R. & Abate, A. R. Concentric electrodes improve microfluidic droplet sorting. Lab Chip 18, 710–713 (2018).
Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545–15550 (2005).
Mootha, V. K. et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34, 267–273 (2003).
Acknowledgements
This work was supported by grants NS102807, ES02530, ES029136, AI126880 from the NIH; RG4111A1 and JF2161-A-5 from the NMSS; RSG-14-198-01-LIB from the American Cancer Society; and PA-1604-08459 from the International Progressive MS Alliance. H.-G.L. was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2021R1A6A3A14039088). J.-H.L. was supported by the Basic Science Research Program funded by the National Research Foundation of Korea (NRF)/Ministry of Education (2022R1A6A3A03071157) and a long-term postdoctoral fellowship funded by the Human Frontier Science Program (LT0015/2023-L). T.I. was supported by the EMBO postdoctoral fellowship (ALTF: 1009-2021). G.P. is a trainee in the Medical Scientist Training Program funded by NIH T32 GM007356. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Science or NIH. M.A.W. was supported by NINDS, NIMH and NCI (R01MH132632, R01MH130458, R00NS114111, T32CA207201). A.P. holds the T1 Canada Research Chair in MS and is funded by the Canada Institute of Health Research, the NMSS and the Canadian Foundation for Innovation. I.C.C. was supported by K22AI152644 and DP2AI154435 from the NIH. The authors thank L. Li for technical assistance; all members of the Quintana laboratory for helpful advice and discussions; R. Krishnan for technical assistance with flow cytometry; and BDRL members K. A. Aldinger, D. Doherty, I. G. Phelps, J. C. Dempsey, K. J. Lee and L. A. Cort.
Author information
Authors and Affiliations
Contributions
H.-G.L., V.R., M.A.W. and F.J.Q. designed the research. H-G.L., J.M.R., C.F.A., J.-H.L., L.E.F., F.P., C.-C.C., L.S., T.I., F.G., M.C., L.M.S., J.E.K., G.P., S.E.J.Z. and V.R. performed experiments. H.-G.L., Z.L., C.F.A., K.L.K. and F.J.Q. performed bioinformatic analyses. S.W.S. performed FIND-seq. J.P.A., A.P. and I.C.C. provided unique reagents and discussed and/or interpreted findings. H.-G.L. and F.J.Q. wrote the paper with input from coauthors. F.J.Q. directed and supervised the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature thanks the anonymous reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Extended data figures and tables
Extended Data Fig. 1 Analysis of astrocyte epigenetic memory in vivo and in vitro.
(a) Fluorescence-activated cell sorting (FACS) sorting schematic for astrocytes, microglia, and monocytes. (b) Volcano plot of differential gene expression increased (red) or decreased (blue) analyzed by RNA-seq of sorted astrocytes. (c) IPA predicted upstream regulators in isolated astrocytes. Up-regulated (red) or down-regulated (blue) in astrocytes stimulated twice (2X IL-1β + TNF) versus once (1X IL-1β + TNF) are shown. (d) GO pathway analysis of ATAC-seq accessible peaks of isolated astrocytes comparing 2X IL-1β + TNF versus 1X IL-1β + TNF. (e) Genome browser snapshots showing the ATAC-seq sequencing tracks at the Tlr2 locus. Only regions showing a significant increase (p-value < 0.05) in accessibility in astrocytes from mice stimulated twice (2X) versus once (1X) are highlighted by yellow boxes. (f) Homer DNA-motif enrichment analyses of differentially accessible peaks. (g) Experimental design for (h) to (j). Primary astrocytes received IL-1β/TNF stimulation once (1X) or twice (2X). (h) qPCR of astrocytes after 30 min activation with IL-1β/TNF on day 7 (n = 5 per group). Unpaired two-sided t-test. (i) Neuronal viability assay (n = 4 control; n = 4 1X; n = 3 2X). Unpaired two-sided t-test. (j) Effect of IL-1β/TNF stimulation on lactate release (n = 6 per group). Unpaired two-sided t-test. (k) qPCR analysis of astrocyte response after the first IL-1β/TNF stimulation (n = 5 per group). Unpaired two-sided t-test. (l) FACS analysis of EGFP expression in IL-1β/TNF stimulated primary astrocytes isolated from p65EGFP reporter mice (0 min; n = 5; Other time point; n = 6 per group). ***P < 0.0001. Unpaired two-sided t-test. (m) FACS sorting schematic of EGFP positive/negative astrocytes after PBS or IL-1β/TNF stimulation for 18-24 h. (n) Primary astrocytes isolated from p65EGFP reporter mice received IL-1β/TNF stimulation. After 18–24 h, EGFP positive astrocytes were sorted and analyzed by FACS of EGFP expression (n = 3-5 per group). Unpaired two-sided t-test. (o) Primary astrocytes isolated from p65EGFP reporter mice received PBS or IL-1β/TNF stimulation. After 18-24 h, EGFP positive/negative astrocytes were sorted and cultured for 6 days to perform qPCR (n = 4 per group). Unpaired two-sided t-test. (p) p65 activation in EGFP positive/negative astrocytes 1 h after IL-1β/TNF stimulation on day 7 (n = 5 per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 2 HAT enzyme expression and regulation of astrocyte epigenetic memory.
(a) EP300, Tip60 (KAT5), and PCAF (KAT2B) signaling network in isolated brain astrocytes that received ICV administration of IL-1β/TNF twice (2X) compared to once (1X). (b) qPCR analysis of Ep300, Kat5, and Kat2b expression in primary astrocytes stimulated after 30 min IL-1β/TNF stimulation on day 7 (n = 4 per group). Unpaired two-sided t-test. (c) Primary astrocytes were stimulated with IL-1β/TNF once (1X), twice (2X), or three times (3X). qPCR analysis of astrocytes after 30 min activation with IL-1β/TNF on day 14 (n = 4 per group). Unpaired two-sided t-test. (d) Experimental design for (e). (e) qPCR of primary astrocytes in the presence with/without C646 (p300/CBP inhibitor), MB-3 (Gcn5/PCAF inhibitor), and MG149 (Tip60 inhibitor) after 30 min stimulation with IL-1β/TNF on day 7 (n = 5 per group). Unpaired two-sided t-test. (f) Experimental design for Fig. 1j. (g) Gene expression 30 min after IL-1β/TNF stimulation on day 7 of EGFP positive/negative astrocytes treated with C646 or vehicle (n = 8 per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 3 Astrocyte epigenetic memory and Ep300 signaling in EAE.
(a) Generation of astrocyte epigenetic memory signature filtered based on adjusted p-value and fold change. Up-signature (red) or down-signature (blue) in astrocytes stimulated twice (2X) than once (1X) are shown. (b) Astrocyte epigenetic memory signature score applied to naive and EAE scRNA-seq astrocyte dataset (Priming, Peak, and Remission)10. (c) Experimental design for (d,e). (d) EAE score for (e) (n = 8 per group). Data shown as mean ± s.e.m. Naïve and EAE induced C57BL/6 mice received ICV administration of IL-1β/TNF (EAE peak, Day 22), and 18-24 h later sorted brain astrocytes were analyzed. (e) qPCR of IL-1β/TNF response of astrocytes (Naïve; n = 12; EAE; n = 8 per group). Representative data of two independent experiments. Unpaired two-sided t-test. (f) Immunostaining (left) and quantification (right) of H3K27ac+ and p300+ astrocytes from sgScrmbl- and sgEp300- transduced mice at 23 days after EAE induction (n = 6 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. (g) FluoroMyelin dye staining and percentage of myelin loss in spinal cord from sgScrmbl- and sgEp300-treated mice (n = 9 spinal cord sections; n = 3 mice per group). Lesions indicated by arrowheads. Unpaired two-sided t-test. (h) NF-kB signaling network comparing sgEp300-transduced versus sgScrmbl-transduced astrocytes. (i) Quantification of CNS-resident cells from sgScrmbl- and sgEp300-transduced mice (n = 9 per group). Unpaired two-sided t-test. (j,k) Analysis of CNS T cells (up) and splenic T cells (bottom) from sgScrmbl- or sgEp300-transduced mice (n = 5 per group). Unpaired two-sided t-test. (l) Genome browser snapshots showing the Relb locus. Only regions showing a significant decrease (p-value < 0.05) in accessibility in sgScrmbl-transduced versus sgEp300-transduced astrocytes are highlighted by yellow boxes. (m) Chip-qPCR analysis of p300 recruitment to promoters in primary astrocytes 30 min after IL-1β/TNF stimulation on day 7 (n = 3 per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 4 ACLY and ACSS2 signaling in EAE astrocytes.
(a) qPCR analysis of Acly and Acss2 expression in primary astrocytes stimulated for 30 min with IL-1β/TNF on day 7 (n = 4 per group). Unpaired two-sided t-test. (b) Primary astrocytes received IL-1β/TNF stimulation once (1X), twice (2X), or three times (3X). qPCR analysis of astrocytes after 30 min activation with IL-1β/TNF on day 14 (n = 4 per group). Unpaired two-sided t-test. (c) Immunostaining (left) and quantification (right) of ACLY+ astrocytes in mice with/without EAE (n = 8 spinal cord sections (naïve); n = 9 spinal cord sections (EAE); n = 3 mice per group). Unpaired two-sided t-test. (d) Immunostaining (left) and quantification (right) of ACSS2+ astrocytes in mice with/without EAE (n = 6 spinal cord sections (naïve); n = 9 spinal cord sections (EAE); n = 3 mice per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 5 Astrocyte Acly signaling and ACLY + p300+ astrocytes in EAE.
(a) Immunostaining (left) and quantification (right) of H3K27ac+ and ACLY+ astrocytes from sgScrmbl- and sgAcly- transduced mice at 21days after EAE induction (n = 6 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. (b) Staining with FluoroMyelin dye and percentage of myelin loss in spinal cord of sgScrmbl- and sgAcly-treated mice (n = 9 spinal cord sections; n = 3 mice per group). Lesions indicated by arrowheads. Unpaired two-sided t-test. (c) Quantification of CNS-resident cells from sgScrmbl- and sgAcly-transduced mice (n = 5 per group). Unpaired two-sided t-test. (d,e) Analysis of CNS T cells (up) and splenic T cells (bottom) from sgScrmbl- or sgAcly-transduced mice (n = 5 per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m. (f) Immunostaining (left) and quantification (right) of ACLY+SOX9+, p300+SOX9+, and ACLY+p300+SOX9+ astrocytes in EAE and control mice (n = 6 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 6 Astrocyte epigenetic memory in NOD EAE.
(a) Experimental design for (c). (b) NOD EAE score for (c) (n = 3 per group). (c) Naïve and EAE induced NOD mice received ICV administration of IL-1β/TNF (EAE progressive, Day 124). After 18-24 h, sorted brain astrocytes were analyzed by qPCR (n = 3 per group). Unpaired two-sided t-test. (d) Immunostaining (left) and quantification (right) of H3K27ac+ and p300+ astrocytes in mice with/without NOD EAE (n = 9 spinal cord sections; n = 3 mice per group). Astrocyte H3K27ac levels were calculated as the mean signal intensity (arbitrary units) per GFAP+ cells using automated unbiased quantification. Unpaired two-sided t-test. (e) Immunostaining (left) and quantification (right) of ACLY+, p300+, and ACLY+p300+ astrocytes in mice with/without NOD EAE (n = 9 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. (f) NOD EAE curves (sgScrmbl; n = 7; sgEp300; n = 8; sgAcly; n = 7). Lentivirus were injected at day 40. Representative data of two independent experiments. Regression slope two-sided t-test compared with sgScrmbl. (g) Volcano plot of differential gene expression determined by RNA-seq in astrocytes isolated from sgScrmbl-, sgEp300-, and sgAcly-transduced mice 64 days after NOD EAE induction (n = 3 sgScrmbl, n = 3 sgEp300, n = 2 sgAcly). (h) GSEA analysis comparing sgScrmbl-, sgEp300-, and sgAcly-transduced astrocytes. (i) Staining with FluoroMyelin dye and percentage of myelin loss from sgScrmbl-, sgEp300-, and sgAcly- transduced mice spinal cord (n = 6 spinal cord sections (sgEp300); n = 9 spinal cord sections (sgScrmbl, sgAcly); n = 3 mice per group. Lesions indicated by arrowheads. Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 7 ACLY and p300 signaling in NOD EAE astrocytes.
(a) Immunostaining (left) and quantification (right) of H3K27ac+ and p300+ astrocytes from sgScrmbl- and sgEp300- transduced NOD mice 64 days after EAE induction (n = 6 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. (b) Immunostaining (left) and quantification (right) of H3K27ac+ and ACLY+ astrocytes from sgScrmbl- and sgAcly- transduced NOD mice 64 days after EAE induction (n = 6 spinal cord sections; n = 3 mice per group). Unpaired two-sided t-test. (c) Quantification of CNS-resident cells from sgScrmbl-, sgEp300, and sgAcly-transduced mice (n = 7 per group). Unpaired two-sided t-test. (d,e) Analysis of CNS T cells (up) and splenic T cells (bottom) from sgScrmbl-, sgEp300, and sgAcly-transduced mice (n = 4 per group). Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Extended Data Fig. 8 Analysis of Acly+Ep300+ astrocytes by FIND-seq.
(a) FACS sorting schematic for tdTomatoGfap astrocytes. (b-d) Schematic illustration of microfluidic devices utilized in FIND-seq. (b) The bubble-triggered device has with five inlets: i) cell inlet, ii) Oligo dT primer-conjugated agarose inlet, iii) lysis buffer inlet, iv) oil inlet, and v) pressurized air inlet. (c) The re-injector device has three inlets: i) agarose bead inlet, ii) TaqMan PCR master mix inlet, and iii) oil inlet. (d) The droplet sorter device has seven inlets: i) emulsion inlet, ii) spacing oil inlet, iii) additional spacing oil inlet, iv) bias oil inlet, v) saltwater inlet (for the electrode), vi) saltwater inlet (for the moat), and vii) pressurized air inlet. (e) Astrocytes are encapsulated in an agarose bead along with the lysis buffer. The genome entrapped in the agarose bead is stained with SYBR Green I and visualized using a fluorescence microscope. (f) cDNA, produced on the agarose bead, is amplified via WTA and validated using a Bioanalyzer. (g) Principal component analysis (PCA) plot of Acly−Ep300−, Acly+Ep300−, Acly−Ep300+, Acly+Ep300+ EAE astrocytes. (h) Violin plot depicting Acly+Ep300+ EAE astrocyte signature expression in EAE astrocytes. (i) IPA pathway analysis up-regulated (red) in cluster 1 astrocytes. (j) EP300-NF-κB signaling network of cluster 1 astrocytes. (k) IPA pathway analysis up-regulated (red) in cluster 10 astrocytes. (l) EP300-NF-κB signaling network of cluster 10 astrocytes.
Extended Data Fig. 9 Analysis of human astrocyte epigenetic memory and MS astrocyte scRNA-seq.
(a) Primary human fetal astrocytes received IL-1β/TNF stimulation once (1X) or twice (2X). qPCR of astrocytes in the presence with/without C646 (p300/CBP inhibitor) after 2 h stimulation with IL-1β/TNF on day 7 (n = 4 per group). Unpaired two-sided t-test. (b) Gene scatterplots of astrocyte markers. (c) Unsupervised clustering UMAP plot of astrocytes from patients with MS and control individuals from Schirmer et al.31 and Absinta et al.30. (n = 16,276 cells). WM, white matter; CI, chronic inactive; CA, chronic active. (d) Significantly enriched genes by astrocyte cell type cluster. (e) Cluster distribution of CNS cells. (f) Violin plot depicting Acly+Ep300+ EAE astrocyte signature expression in MS astrocytes. (g) Astrocyte epigenetic memory signature score in astrocyte clusters of control and MS patients.
Extended Data Fig. 10 ACLY + p300+ astrocytes in MS patients.
(a) Immunostaining and quantification of ACLY+SOX9+, p300+SOX9+, ACLY+p300+SOX9+ astrocytes in CNS samples from MS patients with MS (n = 9 sections (Lesion); n = 6 sections (NAWM); n = 3 per patient) and controls (n = 3 sections; n = 3 per patient). WM, white matter; NAWM, normally appearing white matter. Unpaired two-sided t-test. Data shown as mean ± s.e.m.
Supplementary information
Supplementary Table 1
Differential gene expression of 2× IL-1β+TNF versus 1× IL-1β+TNF astrocytes.
Supplementary Table 2
Differentially accessible gene of 2× IL-1β+TNF versus 1× IL-1β+TNF astrocytes.
Supplementary Table 3
Transcriptional signature of astrocyte epigenetic memory.
Supplementary Table 4
Differential gene expression of sgScrmbl- versus sgEp300-targeted astrocytes during EAE.
Supplementary Table 5
Peaks of H3K27ac ChIP–seq data of sgScrmbl- versus sgEp300-targeted astrocytes during EAE.
Supplementary Table 6
Differential gene expression of sgScrmbl- versus sgAcly-targeted astrocytes during EAE.
Supplementary Table 7
EP300–NF-κB signalling network of sgScrmbl- versus sgAcly-targeted astrocytes during EAE.
Supplementary Table 8
Differential gene expression of sgScrmbl- versus sgEp300- or sgAcly-targeted astrocytes during NOD EAE.
Supplementary Table 9
Transcriptional signature of Acly+Ep300+ EAE astrocytes.
Supplementary Table 10
Differential gene expression by cluster of astrocytes during EAE in TdTomatoGfap mice by scRNA-seq from Wheeler et al.
Supplementary Table 11
ACLY–EP300–NF-κB network of cluster 3 EAE astrocytes.
Supplementary Table 12
Differential gene expression by cluster of astrocytes in multiple sclerosis versus control samples from Schirmer et al. and Absinta et al.
Supplementary Table 13
Clinical information of samples analysed.
Supplementary Table 14
ACLY–EP300–NF-κB network of cluster 2 multiple sclerosis astrocytes.
Source data
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Lee, HG., Rone, J.M., Li, Z. et al. Disease-associated astrocyte epigenetic memory promotes CNS pathology. Nature 627, 865–872 (2024). https://doi.org/10.1038/s41586-024-07187-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-024-07187-5
This article is cited by
-
Astrocyte cells in the brain have immune memory
Nature (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.